$173M
$10,000
0.0% of portfolio
2,380
Q2 2024
New
$187M
$16,000
0.0% of portfolio
4,345
Q2 2024
Reduced 22.2%
$171M
$8,000
0.0% of portfolio
7,234
Q2 2023
New
$377M
$7.68 Million
0.0% of portfolio
2,502,734
Q2 2024
Reduced 5.4%
$351M
$656,000
0.0% of portfolio
31,286
Q2 2024
Added 24.21%
$348M
$642,000
0.0% of portfolio
80,206
Q2 2024
Added 4.88%
$219M
$29,000
0.0% of portfolio
13,329
Q2 2024
Reduced 21.94%
$115M
$9,000
0.0% of portfolio
1,821
Q4 2023
Reduced 13.9%
$1.05B
$638,000
0.0% of portfolio
19,722
Q2 2024
Added 24.56%
$1.03B
$15.6 Million
0.0% of portfolio
1,125,424
Q2 2024
Reduced 11.1%
$5.69B
$12.1 Million
0.0% of portfolio
138,145
Q2 2024
Reduced 41.79%
$2.29B
$8.36 Million
0.0% of portfolio
115,011
Q2 2024
Added 0.2%
$3.4B
$9.28 Million
0.0% of portfolio
183,451
Q2 2024
Added 2.83%
$369M
$25,000
0.0% of portfolio
8,341
Q2 2024
New
$181M
$17,000
0.0% of portfolio
3,480
Q2 2023
New
$4.72B
$12.4 Million
0.0% of portfolio
233,689
Q2 2024
Reduced 2.43%
$5.75B
$10.1 Million
0.0% of portfolio
149,371
Q2 2024
Added 7.7%
$2.54B
$2.16 Million
0.0% of portfolio
132,706
Q2 2024
Added 9.18%
$1.04B
$621,000
0.0% of portfolio
60,550
Q2 2024
Added 20.15%
$510M
$444,000
0.0% of portfolio
94,580
Q2 2024
Added 5.44%
$278M
$285,000
0.0% of portfolio
79,654
Q2 2024
Added 3.22%
$168M
$18,000
0.0% of portfolio
10,239
Q2 2024
Added 5.77%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 10.63%
Achieve Life Sciences Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
$1.06B
$1.15 Million
0.0% of portfolio
49,936
Q2 2024
Added 15.49%
$368M
$26,000
0.0% of portfolio
720
Q3 2023
Reduced 15.19%
-
$0
0.0% of portfolio
-
Q2 2023
Reduced 9.2%
$45.3M
$23,000
0.0% of portfolio
3,133
Q2 2024
Added 3.81%
$8.69B
$15.7 Million
0.0% of portfolio
65,148
Q2 2024
Reduced 6.83%
$100M
$8,000
0.0% of portfolio
3,635
Q2 2024
New
$4.57B
$2.33 Million
0.0% of portfolio
36,702
Q2 2024
Added 7.69%
$2.36B
$2.89 Million
0.0% of portfolio
158,249
Q2 2024
Added 18.81%
$1.5B
$2.31 Million
0.0% of portfolio
231,212
Q2 2024
Added 0.6%
$714M
$35,000
0.0% of portfolio
9,821
Q2 2024
Reduced 90.46%
$239M
$22,000
0.0% of portfolio
7,085
Q2 2024
New
$2.11B
$5.78 Million
0.0% of portfolio
49,767
Q2 2024
Added 8.05%
$1.26B
$899,000
0.0% of portfolio
92,395
Q4 2022
Reduced 16.0%
$1.24B
$3.5 Million
0.0% of portfolio
312,640
Q2 2024
Added 5.29%
$2.25B
$3.85 Million
0.0% of portfolio
155,889
Q2 2024
Added 4.19%
$3.81B
$2.89 Million
0.0% of portfolio
258,483
Q2 2024
Added 15.7%
$6.27B
$2.5 Million
0.0% of portfolio
329,431
Q2 2024
Added 59.61%
$3.41B
$7.89 Million
0.0% of portfolio
115,689
Q2 2024
Added 1.2%
$458M
$203,000
0.0% of portfolio
38,622
Q2 2024
Reduced 81.53%
$2.49B
$13.6 Million
0.0% of portfolio
215,382
Q2 2024
Reduced 4.49%
$3.91B
$11.7 Million
0.0% of portfolio
107,260
Q2 2024
Added 2.65%
$856M
$1.56 Million
0.0% of portfolio
67,973
Q2 2024
Reduced 3.0%
$1.12B
$396,000
0.0% of portfolio
123,245
Q2 2024
Added 12.84%
Adverum Biotechnologies Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
$364M
$34,000
0.0% of portfolio
3,055
Q2 2024
Reduced 88.73%
$83M
$9,000
0.0% of portfolio
3,112
Q2 2024
New